Clinical Trial Update: Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial of ziprasidone for severe conduct disorder and other disruptive behavior disorders has completed. The update does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conduct Disorder
• Oppositional Defiant Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Conduct Disorder, Oppositional Defiant Disorder | Phase 2 | Status: COMPLETED